Jinling Pharmaceutical Company Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,422.221 million compared to CNY 1,143.200 million a year ago. Operating income was CNY 121.810 million compared to CNY 47.798 million a year ago. Net income was CNY 75.957 million compared to CNY 24.373 million a year ago. Basic earnings per share from continuing operations was CNY 0.1507 compared to CNY 0.0484 a year ago.